UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE
OF REPORT (DATE OF EARLIEST EVENT REPORTED):
(EXACT NAME OF REGISTRANT AS SPECIFIED IN
ITS CHARTER)
(STATE OR OTHER JURISDICTION OF INCORPORATION) |
(COMMISSION FILE NUMBER) | (IRS EMPLOYER IDENTIFICATION NO.) |
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE) |
(
(REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA
CODE)
N/A
(FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||
The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02 | Results of Operations and Financial Condition. |
On April 25, 2024, we issued a press release announcing our financial results for the quarter ended March 31, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by this reference.
We are furnishing the information contained in this Item 2.02 (including Exhibit 99.1). It shall not be deemed to be “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, regardless of any general incorporation language in such filing.
Item 9.01 | Financial Statements and Exhibits. |
(d) | Exhibits |
Exhibit 99.1: | Press Release of OSI Systems, Inc. dated April 25, 2024. | ||
Exhibit 104: | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
EXHIBIT INDEX
Exhibit Number |
Description | |
99.1 | Press Release of OSI Systems,Inc. dated April 25, 2024. | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OSI SYSTEMS, INC. | ||
Date: April 25, 2024 | ||
By: | /s/ Alan Edrick | |
Alan Edrick | ||
Executive Vice President and Chief Financial Officer |
Exhibit 99.1
OSI SYSTEMS REPORTS FISCAL 2024 THIRD QUARTER
FINANCIAL RESULTS
● | Record Q3 Revenues of $405 Million (34% growth year-over-year) |
● | Q3 Earnings Per Diluted Share |
o | GAAP Diluted EPS of $1.95 (54% increase year-over-year) |
o | Record Non-GAAP Adjusted Diluted EPS of $2.16 (45% increase year-over-year) |
● | Q3 Operating Income Increase of 50% Year-Over-Year |
● | Strong Bookings Lead to Q3-Ended Backlog of Approximately $1.8 Billion |
● | Company Increases FY 2024 Non-GAAP Adjusted Diluted EPS Guidance |
HAWTHORNE, Calif. — (BUSINESS WIRE) — April 25, 2024 — OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced its financial results for the three and nine months ended March 31, 2024.
Deepak Chopra, OSI Systems’ Chairman and Chief Executive Officer, stated “We are pleased to report strong financial results as outstanding performance in the Security division led to record third quarter revenues and adjusted earnings per share. Given continued solid bookings, a strong backlog, and high visibility into our pipeline of opportunities, we anticipate a strong conclusion to fiscal 2024 and we believe we are well positioned for fiscal 2025.”
For Q3 FY24, the Company reported revenues of $405.4 million, a 34% increase over the $302.9 million reported for the same quarter of the prior year. Net income for Q3 FY24 was $34.0 million, or $1.95 per diluted share, compared to net income of $21.8 million, or $1.27 per diluted share, for the same quarter of the prior year. Non-GAAP net income for Q3 FY24 was $37.7 million, or $2.16 per diluted share, compared to non-GAAP net income for the same quarter of the prior year of $25.6 million, or $1.49 per diluted share.
For the nine months ended March 31, 2024, revenues were $1.06 billion compared to $866.6 million in the same period a year ago. Net income for the nine months ended March 31, 2024 was $83.5 million, or $4.82 per diluted share, compared to $49.4 million, or $2.88 per diluted share, for the same period a year ago. Non-GAAP net income for the nine months ended March 31, 2024 was $91.5 million, or $5.29 per diluted share, compared to non-GAAP net income of $61.0 million, or $3.55 per diluted share, for the same prior-year period.
The Company's book-to-bill ratio was 1.0 for the third quarter of fiscal 2024. As of March 31, 2024, the Company's backlog was approximately $1.8 billion. Capital expenditures were $4.9 million and $5.7 million for Q3 FY24 and Q3 FY23, respectively.
Mr. Chopra commented, “The Security division’s results reflect our tremendous momentum given increasing demand for our product and service offerings as well as our superior competitive position. Security revenues in the third quarter of fiscal 2024 increased 60% year-over-year, which drove significant operating income growth and year-over-year adjusted operating margin expansion in the division. Bookings were again solid and, significantly, even with a substantial conversion of backlog to revenue during the third quarter, the quarter-end backlog remained comparable with the level of last quarter. This further bolsters our confidence that the division’s positive momentum will continue into the future.”
Mr. Chopra continued, “As expected, our Optoelectronics and Manufacturing division reported softer third quarter revenues in part due to certain customers adjusting inventory levels and delaying receipt of deliveries. I am proud of the Optoelectronics and Manufacturing team’s focus on continuous improvement. We anticipate a solid fourth quarter and are well-positioned to take advantage of future growth.”
Mr. Chopra concluded, “The hospital spending environment continued to pose challenges for our Healthcare division. We are highly focused on new product development, principally in our patient monitoring portfolio, to drive future sustainable growth in this division.”
Fiscal Year 2024 Outlook
The Company is reiterating its fiscal 2024 revenues guidance of anticipated growth in excess of 19% over revenues in fiscal 2023. The Company is increasing its non-GAAP adjusted diluted earnings per share guidance from greater than 29% growth to greater than 30% growth compared to non-GAAP adjusted diluted earnings per share for fiscal year 2023. Actual revenues and adjusted diluted earnings per share could vary from this guidance due to factors discussed under “Forward-Looking Statements” or other factors.
The Company’s fiscal 2024 adjusted diluted earnings per share guidance is provided on a non-GAAP basis only. The Company does not provide a reconciliation of guidance for non-GAAP adjusted diluted EPS to GAAP diluted EPS (the most directly comparable GAAP measure) on a forward-looking basis because the Company is unable to provide a meaningful or accurate compilation of reconciling items and certain information is not available. This is due to the inherent difficulty and complexity in accurately forecasting the timing and amounts of various items included in the calculation of GAAP diluted EPS but excluded in the calculation of non-GAAP adjusted diluted EPS, such as acquisition costs and other non-recurring items that have not yet occurred, are out of the Company’s control or cannot otherwise reasonably be predicted. For the same reasons, the Company is unable to address the significance of unavailable information which may be material and therefore could result in GAAP diluted EPS, the most directly comparable GAAP financial measure, being materially different from projected non-GAAP adjusted diluted EPS.
Presentation of Non-GAAP Financial Measures
This earnings release includes a presentation of non-GAAP net income, non-GAAP adjusted diluted earnings per share, non-GAAP operating income (loss) by segment and non-GAAP operating margin, all of which are non-GAAP financial measures. The presentation of these non-GAAP figures for all fiscal periods is provided to allow for the comparison of the underlying performance of the Company, net of impairment, restructuring and other charges (including certain legal costs), amortization of intangible assets acquired through business acquisitions, non-cash interest expense, and their associated tax effects, and the impact of discrete income tax items. Although we exclude amortization of acquired intangible assets from our non-GAAP figures, revenue generated from such intangibles is included within revenue in determining non-GAAP financial performance of the Company. Management believes that the non-GAAP financial measures presented in this earnings release provide (i) enhanced insight into the ongoing operations of the Company, (ii) meaningful information regarding the Company’s financial results (excluding amounts management does not view as reflective of ongoing operating results) for purposes of planning, forecasting and assessing the performance of the Company’s businesses, (iii) a meaningful comparison of financial results of the current period against results of past periods and (iv) financial results that are generally more comparable to financial results of peer companies than are GAAP figures. Non-GAAP financial measures should not be assessed in isolation or as a substitute for measures of financial performance prepared in accordance with GAAP. These non-GAAP measures may not be the same as measures used by other companies due to possible differences in methods and in the items or events for which adjustments are made.
Reconciliations of GAAP financial information to non-GAAP financial information are provided in the accompanying tables. The financial results calculated in accordance with GAAP and reconciliations from those financial results should be carefully evaluated.
Conference Call Information
The Company will host a conference call and simultaneous webcast beginning at 9:00am PT (12:00pm ET) today to discuss its financial results for the periods presented in this earnings release. To listen, please visit the Investor Relations section of the OSI Systems website at http://investors.osi-systems.com/index.cfm and follow the link that will be posted on the front page. A replay of the webcast will be available beginning shortly after the conclusion of the conference call until May 9, 2024. The replay can be accessed through the Company’s website at www.osi-systems.com.
2 |
About OSI Systems
OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries. The Company combines more than 40 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end-product markets. For more information on OSI Systems and its subsidiary companies, visit www.osi-systems.com. News Filter: OSIS-E
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to the Company's current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside the Company's control and which may cause actual results to differ materially from those described in or implied by any forward-looking statement. Forward-looking statements include, but are not limited to, information provided regarding expected revenues, earnings, growth, and operational performance in fiscal 2024 and beyond. The Company could be exposed to a variety of negative consequences as a result of delays related to the award of domestic and international contracts; failure to secure the renewal of key customer contracts; delays in customer programs; delays in revenue recognition related to the timing of customer acceptance; the impact of potential information technology, cybersecurity or data security breaches; changes in domestic and foreign government spending and budgetary, procurement and trade policies adverse to the Company's businesses; the impact of the Russia-Ukraine conflict or conflicts in the Middle East, including the potential for broad economic disruption; global economic uncertainty; material delays and cancellations of orders or deliveries thereon, supply chain disruptions, plant closures, or other adverse impacts on the Company’s ability to execute business plans; unfavorable currency exchange rate fluctuations; unfavorable interest rate fluctuations; effect of changes in tax legislation; market acceptance of the Company's new and existing technologies, products, and services; the Company's ability to win new business and convert orders received to sales within the current fiscal year; contract and regulatory compliance matters, and actions which, if brought, could result in judgments, settlements, fines, injunctions, debarment, or penalties; and other risks and uncertainties, including, but not limited to, those detailed herein and from time to time in the Company's Securities and Exchange Commission filings, which could have a material and adverse impact on the Company's business, financial condition, and results of operations. For additional information on these and other factors that could cause the Company's future results to differ materially from those in any forward-looking statements, see the section titled "Risk Factors" in the Company's most recently filed Annual Report on Form 10-K and other risks described therein and in documents subsequently filed by the Company from time to time with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which are based on currently available information and speak only as of the date on which they are made. The Company assumes no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information, or otherwise, except to the extent required to do so under federal securities laws.
For Additional Information, Contact:
OSI Systems, Inc.
Ajay Vashishat
Vice President, Business Development
Tel: (310) 349-2237
avashishat@osi-systems.com
3 |
OSI SYSTEMS, INC. AND SUBSIDIARIES
UNAUDITED CONDENSED Consolidated Statements of Operations
(in thousands, except per share data)
Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||
2023 | 2024 | 2023 | 2024 | |||||||||||||
Revenues: | ||||||||||||||||
Products | $ | 223,724 | $ | 327,360 | $ | 637,563 | $ | 817,248 | ||||||||
Services | 79,165 | 78,046 | 228,994 | 240,603 | ||||||||||||
Total net revenues | 302,889 | 405,406 | 866,557 | 1,057,851 | ||||||||||||
Cost of goods sold: | ||||||||||||||||
Products | 156,534 | 223,570 | 458,197 | 547,938 | ||||||||||||
Services | 42,569 | 45,741 | 120,870 | 133,772 | ||||||||||||
Total cost of goods sold | 199,103 | 269,311 | 579,067 | 681,710 | ||||||||||||
Gross profit | 103,786 | 136,095 | 287,490 | 376,141 | ||||||||||||
Operating expenses: | ||||||||||||||||
Selling, general and administrative | 53,707 | 66,584 | 161,148 | 197,986 | ||||||||||||
Research and development | 14,852 | 17,144 | 43,848 | 49,416 | ||||||||||||
Restructuring and other charges, net | 890 | 1,004 | 4,366 | 2,496 | ||||||||||||
Total operating expenses | 69,449 | 84,732 | 209,362 | 249,898 | ||||||||||||
Income from operations | 34,337 | 51,363 | 78,128 | 126,243 | ||||||||||||
Interest and other expense, net | (5,727 | ) | (7,407 | ) | (14,339 | ) | (19,689 | ) | ||||||||
Income before income taxes | 28,610 | 43,956 | 63,789 | 106,554 | ||||||||||||
Provision for income taxes | (6,802 | ) | (9,913 | ) | (14,392 | ) | (23,079 | ) | ||||||||
Net income | $ | 21,808 | $ | 34,043 | $ | 49,397 | $ | 83,475 | ||||||||
Diluted earnings per share | $ | 1.27 | $ | 1.95 | $ | 2.88 | $ | 4.82 | ||||||||
Weighted average shares outstanding – diluted | 17,184 | 17,425 | 17,151 | 17,301 |
UNAUDITED Segment Information
(in thousands)
Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||
2023 | 2024 | 2023 | 2024 | |||||||||||||
Revenues – by Segment: | ||||||||||||||||
Security division | $ | 178,752 | $ | 285,960 | $ | 491,188 | $ | 700,564 | ||||||||
Optoelectronics and Manufacturing division, including intersegment revenues | 93,888 | 87,974 | 286,513 | 282,199 | ||||||||||||
Healthcare division | 43,911 | 41,493 | 130,994 | 121,130 | ||||||||||||
Intersegment eliminations | (13,662 | ) | (10,021 | ) | (42,138 | ) | (46,042 | ) | ||||||||
Total | $ | 302,889 | $ | 405,406 | $ | 866,557 | $ | 1,057,851 | ||||||||
Operating income (loss) – by Segment: | ||||||||||||||||
Security division | $ | 29,496 | $ | 50,127 | $ | 66,014 | $ | 122,592 | ||||||||
Optoelectronics and Manufacturing division | 12,493 | 9,435 | 35,963 | 32,493 | ||||||||||||
Healthcare division | 1,787 | 1,564 | 4,819 | 2,157 | ||||||||||||
Corporate | (10,148 | ) | (9,733 | ) | (29,572 | ) | (30,832 | ) | ||||||||
Intersegment eliminations | 709 | (30 | ) | 904 | (167 | ) | ||||||||||
Total | $ | 34,337 | $ | 51,363 | $ | 78,128 | $ | 126,243 |
4 |
OSI SYSTEMS, INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
June 30, 2023 | March 31, 2024 | |||||||
Assets | ||||||||
Cash and cash equivalents | $ | 76,750 | $ | 101,443 | ||||
Accounts receivable, net | 380,845 | 503,828 | ||||||
Inventories | 338,008 | 442,797 | ||||||
Prepaid expenses and other current assets | 44,300 | 71,182 | ||||||
Total current assets | 839,903 | 1,119,250 | ||||||
Property and equipment, net | 108,933 | 110,399 | ||||||
Goodwill | 349,505 | 352,119 | ||||||
Intangible assets, net | 140,857 | 142,056 | ||||||
Other non-current assets | 116,488 | 107,251 | ||||||
Total Assets | $ | 1,555,686 | $ | 1,831,075 | ||||
Liabilities and Stockholders' Equity | ||||||||
Bank lines of credit | $ | 215,000 | $ | 349,000 | ||||
Current portion of long-term debt | 8,076 | 8,212 | ||||||
Accounts payable and accrued expenses | 208,786 | 237,310 | ||||||
Other current liabilities | 139,832 | 167,160 | ||||||
Total current liabilities | 571,694 | 761,682 | ||||||
Long-term debt | 136,491 | 131,214 | ||||||
Other long-term liabilities | 121,336 | 124,766 | ||||||
Total liabilities | 829,521 | 1,017,662 | ||||||
Total stockholders’ equity | 726,165 | 813,413 | ||||||
Total Liabilities and Stockholders’ Equity | $ | 1,555,686 | $ | 1,831,075 |
5 |
Reconciliation
of GAAP to Non-GAAP
NET INCOME AND EARNINGS PER SHARE
(in thousands, except earnings per share data)
Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||||||||
2023 | 2024 | 2023 | 2024 | |||||||||||||||||||||||||||||
Net income | EPS | Net income | EPS | Net income | EPS | Net income | EPS | |||||||||||||||||||||||||
GAAP basis | $ | 21,808 | $ | 1.27 | $ | 34,043 | $ | 1.95 | $ | 49,397 | $ | 2.88 | $ | 83,475 | $ | 4.82 | ||||||||||||||||
Restructuring and other charges, net | 890 | 0.05 | 1,004 | 0.06 | 4,366 | 0.25 | 2,496 | 0.14 | ||||||||||||||||||||||||
Amortization of acquired intangible assets | 3,738 | 0.22 | 3,881 | 0.22 | 11,226 | 0.65 | 12,268 | 0.71 | ||||||||||||||||||||||||
Non-cash interest expense | 124 | 0.01 | - | - | 419 | 0.02 | - | - | ||||||||||||||||||||||||
Tax benefit of above adjustments | (1,102 | ) | (0.07 | ) | (1,088 | ) | (0.06 | ) | (3,775 | ) | (0.21 | ) | (3,632 | ) | (0.20 | ) | ||||||||||||||||
Discrete tax expense (benefit) | 168 | 0.01 | (180 | ) | (0.01 | ) | (646 | ) | (0.04 | ) | (3,133 | ) | (0.18 | ) | ||||||||||||||||||
Non-GAAP basis | $ | 25,626 | $ | 1.49 | $ | 37,660 | $ | 2.16 | $ | 60,987 | $ | 3.55 | $ | 91,474 | $ | 5.29 |
RECONCILIATION OF GAAP TO NON-GAAP
OPERATING INCOME (LOSS) AND OPERATING MARGIN BY SEGMENT
(in thousands, except percentages)
Three Months Ended March 31, 2023 | ||||||||||||||||||||||||||||||||||||
Security Division | Optoelectronics
and Manufacturing Division | Healthcare Division | Corporate
/ Elimination | Total | ||||||||||||||||||||||||||||||||
% of Sales | % of Sales | % of Sales | % of Sales | |||||||||||||||||||||||||||||||||
GAAP basis – operating income (loss) | $ | 29,496 | 16.5 | % | $ | 12,493 | 13.3 | % | $ | 1,787 | 4.1 | % | $ | (9,439 | ) | $ | 34,337 | 11.3 | % | |||||||||||||||||
Restructuring and other charges, net | 493 | 0.3 | % | 32 | 0.1 | % | 307 | 0.7 | % | 58 | 890 | 0.3 | % | |||||||||||||||||||||||
Amortization of acquired intangible assets | 2,784 | 1.5 | % | 686 | 0.7 | % | 268 | 0.6 | % | - | 3,738 | 1.3 | % | |||||||||||||||||||||||
Non-GAAP basis– operating income (loss) | $ | 32,773 | 18.3 | % | $ | 13,211 | 14.1 | % | $ | 2,362 | 5.4 | % | $ | (9,381 | ) | $ | 38,965 | 12.9 | % |
Three Months Ended March 31, 2024 | ||||||||||||||||||||||||||||||||||||
Security Division | Optoelectronics
and Manufacturing Division | Healthcare Division | Corporate
/ Elimination | Total | ||||||||||||||||||||||||||||||||
% of Sales | % of Sales | % of Sales | % of Sales | |||||||||||||||||||||||||||||||||
GAAP basis – operating income (loss) | $ | 50,127 | 17.5 | % | $ | 9,435 | 10.7 | % | $ | 1,564 | 3.8 | % | $ | (9,763 | ) | $ | 51,363 | 12.7 | % | |||||||||||||||||
Restructuring and other charges, net | 185 | 0.1 | % | 504 | 0.6 | % | 311 | 0.7 | % | 4 | 1,004 | 0.2 | % | |||||||||||||||||||||||
Amortization of acquired intangible assets | 2,800 | 1.0 | % | 780 | 0.9 | % | 301 | 0.7 | % | - | 3,881 | 1.0 | % | |||||||||||||||||||||||
Non-GAAP basis– operating income (loss) | $ | 53,112 | 18.6 | % | $ | 10,719 | 12.2 | % | $ | 2,176 | 5.2 | % | $ | (9,759 | ) | $ | 56,248 | 13.9 | % |
6 |
Nine Months Ended March 31, 2023 | ||||||||||||||||||||||||||||||||||||
Security Division | Optoelectronics
and Manufacturing Division | Healthcare Division | Corporate
/ Elimination | Total | ||||||||||||||||||||||||||||||||
% of Sales | % of Sales | % of Sales | % of Sales | |||||||||||||||||||||||||||||||||
GAAP basis – operating income (loss) | $ | 66,014 | 13.4 | % | $ | 35,963 | 12.6 | % | $ | 4,819 | 3.7 | % | $ | (28,668 | ) | $ | 78,128 | 9.0 | % | |||||||||||||||||
Restructuring and other charges, net | 1,358 | 0.3 | % | 47 | 0.0 | % | 2,753 | 2.1 | % | 208 | 4,366 | 0.5 | % | |||||||||||||||||||||||
Amortization of acquired intangible assets | 8,487 | 1.7 | % | 2,068 | 0.7 | % | 671 | 0.5 | % | - | 11,226 | 1.3 | % | |||||||||||||||||||||||
Non-GAAP basis– operating income (loss) | $ | 75,859 | 15.4 | % | $ | 38,078 | 13.3 | % | $ | 8,243 | 6.3 | % | $ | (28,460 | ) | $ | 93,720 | 10.8 | % |
Nine Months Ended March 31, 2024 | ||||||||||||||||||||||||||||||||||||
Security Division | Optoelectronics
and Manufacturing Division | Healthcare Division | Corporate
/ Elimination | Total | ||||||||||||||||||||||||||||||||
% of Sales | % of Sales | % of Sales | % of Sales | |||||||||||||||||||||||||||||||||
GAAP basis – operating income (loss) | $ | 122,592 | 17.5 | % | $ | 32,493 | 11.5 | % | $ | 2,157 | 1.8 | % | $ | (30,999 | ) | $ | 126,243 | 11.9 | % | |||||||||||||||||
Restructuring and other charges, net | 621 | 0.1 | % | 1,080 | 0.4 | % | 311 | 0.3 | % | 484 | 2,496 | 0.2 | % | |||||||||||||||||||||||
Amortization of acquired intangible assets | 8,766 | 1.2 | % | 2,598 | 0.9 | % | 904 | 0.7 | % | - | 12,268 | 1.2 | % | |||||||||||||||||||||||
Non-GAAP basis– operating income (loss) | $ | 131,979 | 18.8 | % | $ | 36,171 | 12.8 | % | $ | 3,372 | 2.8 | % | $ | (30,515 | ) | $ | 141,007 | 13.3 | % |
7 |